Drugs like "Ozempic" have led to a rise in pregnancies known as "Ozempic babies." Halting these medications at the start of pregnancy may increase health risks, according to the New York Post.

Research from Massachusetts General Brigham Hospital found that women who stopped GLP-1 drugs such as "Ozempic" and "Wegovy" before or in early pregnancy gained an average of 7.2 kilograms more than women who never used them.

The study also showed higher health risks, including gestational diabetes, preterm birth, and pregnancy-related high blood pressure.

GLP-1 drugs mimic natural gut hormones, regulating blood sugar and suppressing appetite.

Stopping them removes these effects quickly, often causing weight regain and loss of appetite control.

Previous use of these medications was linked to higher gestational diabetes rates.

Neglecting this condition may lead to serious complications for mother and child, such as heart problems for the mother and future obesity in the child.

The study warned that high blood pressure during pregnancy could cause life-threatening issues like strokes and heart attacks.

On the positive side, stopping GLP-1 drugs did not increase cesarean deliveries or affect newborn weight or length.

However, the findings highlight a gap in knowledge on caring for women who used these drugs before pregnancy.

Dr. Camille Po, the lead researcher, called for more studies to balance the benefits of GLP-1 drugs with the risks of stopping them suddenly.

She stressed the need for better protocols to manage weight and reduce health risks during this critical period.